FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013222531> ?p ?o ?g. }

• W2013222531 endingPage "6" @default.
• W2013222531 startingPage "6" @default.
• W2013222531 abstract "Pharmacognosy Research,2014,6,1,6-11.DOI:10.4103/0974-8490.122911Published:December,2013Type:Original ArticleAuthors:Muhammad Ovais Omer, Waleed Hassan AlMalki, Imran Shahid, Shahzada Khuram, Imran Altaf, and Saeed Imran Author(s) affiliations:Muhammad Ovais Omer1, Waleed Hassan AlMalki2, Imran Shahid2, Shahzada Khuram1, Imran Altaf3, Saeed Imran3 1Department of Pharmacology and Toxicology, University of Veterinary and Animal Sciences, Lahore, Pakistan. 2Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, P. O. Box 13174, Makkah, Saudi Arabia. 3WTO Quality Control Lab, Department of Pathology, University of Veterinary and Animal Sciences, Lahore, Pakistan. Abstract:Background: The Newcastle disease represents as one of the most infectious viral disease, which afflicts almost every species of the birds. The causative agent of the disease is a single-stranded RNA virus with rapid replication capability. Objective: This study was performed to evaluate the comparative anti-viral efficacy and toxicity of Glycyrrhiza glabra aqueous extract and ribavirin against the Newcastle disease virus. Materials and Methods: The embryonated eggs were divided into six groups (A, B, C, D, E and F). Groups A, B, C, and D were further subdivided into three subgroups. The virus was identified by hemagglutination inhibition test. Spot hemagglutination test and viability of embryos were also evaluated. Three different concentrations i-e., 30 mg/100 ml, 60 mg/100 ml, and 120 mg/100 ml of the Glycyrrhiza aqueous extract and 10 μg/ml, 20 μg/ml, and 40 μg/ml ribavirin in deionized water were evaluated for their toxicity and anti-viral activity in the embryonated eggs. Results: 60 mg/100 ml concentration of Glycyrrhiza extract did not produce any toxicity in the embryonated eggs and showed anti-viral activity against the virus. Similarly, 20 μg/ml ribavirin was non-toxic in the embryonated eggs and contained anti-viral activity. Conclusion: It may conclude from the presented study that 60 mg/100 ml Glycyrrhiza extract inhibits replication of Newcastle disease virus and is non-toxic in the embryonated eggs. So, Glycyrrhiza glabra extract may be further evaluated in future to determine the potentially active compounds for their anti-viral activity against Newcastle disease virus. Furthermore, the mechanism of action of these active phytochemicals as an antiviral agent would be helpful to elucidate the pathogenesis of the disease. Keywords:Anti-viral agents, Embryonated eggs, Glycyrrhiza glabra, Newcastle disease virus, RibavirinView:PDF (506.65 KB)" @default.
• W2013222531 created "2016-06-24" @default.
• W2013222531 creator A5004794264 @default.
• W2013222531 creator A5026550337 @default.
• W2013222531 creator A5048765899 @default.
• W2013222531 creator A5054997228 @default.
• W2013222531 creator A5056209135 @default.
• W2013222531 creator A5089494466 @default.
• W2013222531 date "2014-01-01" @default.
• W2013222531 modified "2023-09-30" @default.
• W2013222531 title "Comparative study to evaluate the anti-viral efficacy of Glycyrrhiza glabra extract and ribavirin against the Newcastle disease virus" @default.
• W2013222531 cites W1934976864 @default.
• W2013222531 cites W1966089579 @default.
• W2013222531 cites W1977828927 @default.
• W2013222531 cites W1983863966 @default.
• W2013222531 cites W1983899108 @default.
• W2013222531 cites W1991188594 @default.
• W2013222531 cites W1994314664 @default.
• W2013222531 cites W1994411312 @default.
• W2013222531 cites W1997484123 @default.
• W2013222531 cites W2010364951 @default.
• W2013222531 cites W2017806176 @default.
• W2013222531 cites W2020430828 @default.
• W2013222531 cites W2022848146 @default.
• W2013222531 cites W2029157859 @default.
• W2013222531 cites W2036595566 @default.
• W2013222531 cites W2043685036 @default.
• W2013222531 cites W2050011032 @default.
• W2013222531 cites W2050926784 @default.
• W2013222531 cites W2068329523 @default.
• W2013222531 cites W2070309534 @default.
• W2013222531 cites W2092005960 @default.
• W2013222531 cites W2099222314 @default.
• W2013222531 cites W2099843722 @default.
• W2013222531 cites W2112100526 @default.
• W2013222531 cites W2122648060 @default.
• W2013222531 cites W2125495568 @default.
• W2013222531 cites W2128252769 @default.
• W2013222531 cites W2134504952 @default.
• W2013222531 cites W2135715865 @default.
• W2013222531 cites W2143569077 @default.
• W2013222531 cites W2300354804 @default.
• W2013222531 cites W2334427329 @default.
• W2013222531 cites W40431867 @default.
• W2013222531 cites W2419367020 @default.
• W2013222531 doi "https://doi.org/10.4103/0974-8490.122911" @default.
• W2013222531 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3897011" @default.
• W2013222531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24497736" @default.
• W2013222531 hasPublicationYear "2014" @default.
• W2013222531 type Work @default.
• W2013222531 sameAs 2013222531 @default.
• W2013222531 citedByCount "18" @default.
• W2013222531 countsByYear W20132225312014 @default.
• W2013222531 countsByYear W20132225312015 @default.
• W2013222531 countsByYear W20132225312016 @default.
• W2013222531 countsByYear W20132225312017 @default.
• W2013222531 countsByYear W20132225312018 @default.
• W2013222531 countsByYear W20132225312019 @default.
• W2013222531 countsByYear W20132225312020 @default.
• W2013222531 countsByYear W20132225312021 @default.
• W2013222531 countsByYear W20132225312022 @default.
• W2013222531 countsByYear W20132225312023 @default.
• W2013222531 crossrefType "journal-article" @default.
• W2013222531 hasAuthorship W2013222531A5004794264 @default.
• W2013222531 hasAuthorship W2013222531A5026550337 @default.
• W2013222531 hasAuthorship W2013222531A5048765899 @default.
• W2013222531 hasAuthorship W2013222531A5054997228 @default.
• W2013222531 hasAuthorship W2013222531A5056209135 @default.
• W2013222531 hasAuthorship W2013222531A5089494466 @default.
• W2013222531 hasBestOaLocation W20132225311 @default.
• W2013222531 hasConcept C129470801 @default.
• W2013222531 hasConcept C142724271 @default.
• W2013222531 hasConcept C159047783 @default.
• W2013222531 hasConcept C204787440 @default.
• W2013222531 hasConcept C2522874641 @default.
• W2013222531 hasConcept C2776408679 @default.
• W2013222531 hasConcept C2778116459 @default.
• W2013222531 hasConcept C2778993495 @default.
• W2013222531 hasConcept C2780040827 @default.
• W2013222531 hasConcept C556039675 @default.
• W2013222531 hasConcept C71924100 @default.
• W2013222531 hasConcept C86803240 @default.
• W2013222531 hasConcept C98274493 @default.
• W2013222531 hasConceptScore W2013222531C129470801 @default.
• W2013222531 hasConceptScore W2013222531C142724271 @default.
• W2013222531 hasConceptScore W2013222531C159047783 @default.
• W2013222531 hasConceptScore W2013222531C204787440 @default.
• W2013222531 hasConceptScore W2013222531C2522874641 @default.
• W2013222531 hasConceptScore W2013222531C2776408679 @default.
• W2013222531 hasConceptScore W2013222531C2778116459 @default.
• W2013222531 hasConceptScore W2013222531C2778993495 @default.
• W2013222531 hasConceptScore W2013222531C2780040827 @default.
• W2013222531 hasConceptScore W2013222531C556039675 @default.
• W2013222531 hasConceptScore W2013222531C71924100 @default.
• W2013222531 hasConceptScore W2013222531C86803240 @default.
• W2013222531 hasConceptScore W2013222531C98274493 @default.
• W2013222531 hasIssue "1" @default.
• W2013222531 hasLocation W20132225311 @default.

• next